Privacy & Cybersecurity
Viewpoints
Filter by:
FBI Director Wray Says FBI Blocked Planned Cyberattack on Boston Children’s Hospital
June 1, 2022 | Blog | By Cynthia Larose
FBI Director Christopher Wray said that agents this summer thwarted a planned attack on Boston Children’s Hospital. Wray said that the FBI learned of the plan from “an intelligence partner,” and “quick actions by everyone involved, especially at the hospital, protected both the network and the sick kids who depended on it.”
Connecticut is on the Privacy Move
May 4, 2022 | Blog | By Christopher Buontempo , Cynthia Larose
Connecticut Governor Ned Lamont has signed the country’s fifth comprehensive consumer privacy act. Our breakdown below outlines key concepts on how the Connecticut Data Privacy Act (CDPA) will impact businesses, and several notes about how its provisions compare to other US state privacy laws.
Health Care Organizations Warned of Aggressive Ransomware Threat
April 28, 2022 | Blog | By Cynthia Larose
Ransomware is the “business pandemic.” Warnings have been issued by multiple agencies around the world to alert businesses to increase their protection and awareness. Most recently, the Department of Health and Human Services (HHS) has issued a warning to health care organizations related to what it calls “an exceptionally aggressive” ransomware group known as Hive.
President Says Russia “Exploring” Cyberattacks Against U.S.
March 21, 2022 | Blog | By Cynthia Larose
On March 21, President Biden warned U.S. companies to be on guard against Russian cyberattacks, citing intelligence as a call to action.
Utah Consumer Privacy Act – Mintz’s Hot Take
March 17, 2022 | Blog | By Cynthia Larose, Christopher Buontempo
Utah is on the brink of joining California, Colorado, and Virginia to become the fourth state in the US to enact a major comprehensive privacy law. On February 25, the Utah Senate passed the Utah Consumer Privacy Act (“UCPA”), and on March 2, it was passed by the Utah House. The Mintz privacy team has reviewed the UCPA for answers to business’ most pressing questions about how this new law will affect them if it is enacted.
Facebook to Pay $90 Million to Settle Data Privacy Lawsuit
February 18, 2022 | Blog | By Cynthia Larose
The New UK International Data Transfer Agreement Is Ready To Go From March 21, 2022
February 1, 2022 | Blog
SEC Chair Gensler Wants Public Companies to Upgrade “Cyber Hygiene”
January 24, 2022 | Blog | By Cynthia Larose
FTC Warns Companies to Remediate Log4j Security Vulnerability
January 5, 2022 | Blog | By Cynthia Larose
When Can a Trademark Owner Take Action for Unauthorized Use of its Trademark Online?
January 4, 2022 | Blog | By Susan Neuberger Weller
Time to Update Your Incident Response Plans
October 22, 2021 | Blog | By Cynthia Larose
Privacy Implications of the Facebook Whistleblower Testimony
October 20, 2021 | Blog | By Cynthia Larose, Christian Tamotsu Fjeld
California’s Senate Bill 41: The Genetic Information Privacy Act
October 19, 2021 | Blog | By Stephnie John, Lara Compton
California Update
October 7, 2021 | Blog | By Cynthia Larose
California Legislature Passes New Key Privacy Laws, Expected to Be Signed Next Week
October 4, 2021 | Blog
What We’re Reading – September 24, 2021
September 24, 2021 | Blog | By Cynthia Larose
California’s New Privacy Regulator Invites You to Comment
September 23, 2021 | Blog | By Cynthia Larose
California Health Privacy Information Legislation Update
September 22, 2021 | Blog | By Lara Compton, Stephnie John
FTC Personal Health Records Breach Rule Applies to Health App and Connected Device Developers
September 21, 2021 | Blog | By Lara Compton
What We’re Reading – September 17, 2021
September 17, 2021 | Blog | By Cynthia Larose
Explore Other Viewpoints:
- AI: The Washington Report
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Cannabis
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Corporate Governance (ESG)
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- Energy & Sustainability
- Environmental (ESG)
- Environmental Enforcement Defense
- Environmental Law
- Environmental, Social, and Corporate Governance (ESG)
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Impacts of a New US Administration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Social (ESG)
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology